Back to results
US 2022/0009910 A1Published application
Tyrosine kinase 2 inhibitors, preparation methods and medicinal uses thereof
AssigneeEternity Bioscience Inc.
InventorsLinghang Zhuang, Jian Liu, Yinfa Yan, Puhui Li, Yu Zhou, Suxing Liu
Life of this patent
Estimating the term…
Abstract
This application discloses Tyk-2 inhibitors represented by the general formula (I) and analogs thereof, pharmaceutical compositions containing these compounds, method of preparing them, and use of these compounds as therapeutic agents for the treatment of diseases or conditions associated with Tyk-2 activity, such as autoimmune diseases and cancers.
Claims25
A compound of formula (I), or a tautomer, mesomer, racemate, enantiomer, diastereomer, or mixture thereof, or a pharmaceutically acceptable salt, solvate, or prodrug thereof:
- wherein:
- G1 is N atom or C atom;
- G2 and G3 are identical or different, and each is independently selected from the group consisting of C atom, O atom, N atom and S atom, provided that at least one of G1, G2 and G3 is a heteroatom;
- W1 and W2 are identical or different, and each is independently N atom or CR6;
- L is selected from the group consisting of a bond, O atom and alkylene, wherein the alkylene is optionally substituted with one or more groups independently selected from the group consisting of halogen, alkyl, alkoxy, hydroxyl, hydroxyalkyl, cyano, amino, nitro, cycloalkyl, heterocyclyl, aryl and heteroaryl;
- ring A is heteroaryl;
- R1 is selected from the group consisting of hydrogen, alkyl, deuterated alkyl, haloalkyl, hydroxyalkyl, alkenyl, alkynyl and —C(O)R7;
- R2 is selected from the group consisting of hydrogen, halogen, alkyl, deuterated alkyl, alkenyl, alkynyl, alkoxy, haloalkyl, haloalkoxy, hydroxyl, hydroxyalkyl, cyano, amino, nitro, cycloalkyl and heterocyclyl;
- R3 is selected from the group consisting of hydrogen, halogen, alkyl, deuterated alkyl, alkenyl, alkynyl, alkoxy, haloalkyl, haloalkoxy, hydroxyl, hydroxyalkyl, cyano, amino nitro, cycloalkyl and heterocyclyl;
- R4 at each occurrence is independently selected from the group consisting of hydrogen, halogen, alkyl, deuterated alkyl, alkenyl, alkynyl, alkoxy, haloalkyl, haloalkoxy, hydroxyl, hydroxyalkyl, cyano, amino, nitro, cycloalkyl, heterocyclyl, aryl and heteroaryl;
- R5 at each occurrence is independently selected from the group consisting of hydrogen, halogen, alkyl, oxo, alkenyl, alkynyl, alkoxy, haloalkyl, haloalkoxy, hydroxyl, hydroxyalkyl, cyano, amino, nitro, cycloalkyl, heterocyclyl, aryl and heteroaryl;
- R6 is selected from the group consisting of hydrogen, halogen, alkyl, alkenyl, alkynyl, deuterated alkyl, alkoxy, haloalkyl, haloalkoxy, hydroxyl, hydroxyalkyl, cyano, amino, nitro, cycloalkyl, heterocyclyl, aryl and heteroaryl;
- R7 is selected from the group consisting of alkyl, alkenyl, alkynyl, haloalkyl, hydroxyalkyl, cycloalkyl and heterocyclyl;
- n is 0, 1, 2, 3 or 4;
- and
- t is 0, 1, 2 or 3.
13 more elements
Dependencies are inferred from the claim text.